Psoriasis, a chronic inflammatory disease affecting 2-3% of the global population, poses significant challenges due to the side effects and recurrence of conventional treatments. This article delves into the potential of mesenchymal stem cells (MSCs) and their extracellular vesicles as a promising therapeutic alternative. With immunomodulatory and regenerative properties, MSCs have shown to reduce inflammation…